Hanson GR - Search Results

1

Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications.

Fleckenstein AE, Volz TJ, Hanson GR. Fleckenstein AE, et al. Among authors: hanson gr. Neuropharmacology. 2009;56 Suppl 1(Suppl 1):133-8. doi: 10.1016/j.neuropharm.2008.07.002. Epub 2008 Jul 10. Neuropharmacology. 2009. PMID: 18662707 Free PMC article. Review.

2

Tolerance to the neurotoxic effects of methamphetamine in young rats.

Riddle EL, Kokoshka JM, Wilkins DG, Hanson GR, Fleckenstein AE. Riddle EL, et al. Among authors: hanson gr. Eur J Pharmacol. 2002 Jan 25;435(2-3):181-5. doi: 10.1016/s0014-2999(01)01592-8. Eur J Pharmacol. 2002. PMID: 11821024

3

Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.

Hansen JP, Riddle EL, Sandoval V, Brown JM, Gibb JW, Hanson GR, Fleckenstein AE. Hansen JP, et al. Among authors: hanson gr. J Pharmacol Exp Ther. 2002 Mar;300(3):1093-100. doi: 10.1124/jpet.300.3.1093. J Pharmacol Exp Ther. 2002. PMID: 11861820

4

A single methamphetamine administration rapidly decreases vesicular dopamine uptake.

Brown JM, Riddle EL, Sandoval V, Weston RK, Hanson JE, Crosby MJ, Ugarte YV, Gibb JW, Hanson GR, Fleckenstein AE. Brown JM, et al. Among authors: hanson je, hanson gr. J Pharmacol Exp Ther. 2002 Aug;302(2):497-501. doi: 10.1124/jpet.302.2.497. J Pharmacol Exp Ther. 2002. PMID: 12130707

5

Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine.

Riddle EL, Topham MK, Haycock JW, Hanson GR, Fleckenstein AE. Riddle EL, et al. Among authors: hanson gr. Eur J Pharmacol. 2002 Aug 2;449(1-2):71-4. doi: 10.1016/s0014-2999(02)01985-4. Eur J Pharmacol. 2002. PMID: 12163108

6

Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors.

Sandoval V, Riddle EL, Hanson GR, Fleckenstein AE. Sandoval V, et al. Among authors: hanson gr. J Neurosci. 2002 Oct 1;22(19):8705-10. doi: 10.1523/JNEUROSCI.22-19-08705.2002. J Neurosci. 2002. PMID: 12351745 Free PMC article.

7

Inhibitory effect of reserpine on dopamine transporter function.

Metzger RR, Brown JM, Sandoval V, Rau KS, Elwan MA, Miller GW, Hanson GR, Fleckenstein AE. Metzger RR, et al. Among authors: hanson gr. Eur J Pharmacol. 2002 Dec 5;456(1-3):39-43. doi: 10.1016/s0014-2999(02)02647-x. Eur J Pharmacol. 2002. PMID: 12450567

8

Ceramide-induced alterations in dopamine transporter function.

Riddle EL, Rau KS, Topham MK, Hanson GR, Fleckenstein AE. Riddle EL, et al. Among authors: hanson gr. Eur J Pharmacol. 2003 Jan 1;458(1-2):31-6. doi: 10.1016/s0014-2999(02)02727-9. Eur J Pharmacol. 2003. PMID: 12498904

9

Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits.

Sandoval V, Riddle EL, Hanson GR, Fleckenstein AE. Sandoval V, et al. Among authors: hanson gr. J Pharmacol Exp Ther. 2003 Mar;304(3):1181-7. doi: 10.1124/jpet.102.045005. J Pharmacol Exp Ther. 2003. PMID: 12604695

10

Methamphetamine rapidly decreases mouse vesicular dopamine uptake: role of hyperthermia and dopamine D2 receptors.

Ugarte YV, Rau KS, Riddle EL, Hanson GR, Fleckenstein AE. Ugarte YV, et al. Among authors: hanson gr. Eur J Pharmacol. 2003 Jul 11;472(3):165-71. doi: 10.1016/s0014-2999(03)01911-3. Eur J Pharmacol. 2003. PMID: 12871750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

361 results

Search Page